Literature DB >> 15979815

Do behavioral smoking reduction approaches reach more or different smokers? Two studies; similar answers.

Russell E Glasgow1, Bridget Gaglio, Eric K France, Al Marcus, Kimberly M Riley, Arnold Levinson, Kimberly Bischoff.   

Abstract

There is a need for innovative approaches capable of reaching smokers who would not otherwise participate in efforts to modify their smoking. This paper reports on two studies to determine whether a smoking reduction intervention would appeal to additional or different types of smokers than do cessation interventions. Study 1 attempted to contact 160 HMO smokers scheduled for outpatient surgeries. In Study 2, actual pilot reduction and cessation programs were offered to 531 smokers about to undergo out-patient surgeries or procedures. In Study 1, 39% of those eligible elected smoking reduction; and 38% selected cessation. In Study 2 of those eligible, 22% began participation in the smoking reduction program; 12% preferred a cessation approach; and 65% declined. There were few demographic or smoking history differences among those who elected smoking reduction, cessation, or declined. Among this understudied population, a sizable proportion in both studies agreed to participate in smoking reduction. If replicated, this suggests that comprehensive programs that include a smoking reduction component could substantially increase their reach.

Entities:  

Mesh:

Year:  2005        PMID: 15979815     DOI: 10.1016/j.addbeh.2005.05.039

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  7 in total

1.  Smokeless tobacco reduction with the nicotine lozenge and behavioral intervention.

Authors:  Jon O Ebbert; Amanda Edmonds; Xianghua Luo; Joni Jensen; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2010-06-04       Impact factor: 4.244

Review 2.  Do smoking reduction interventions promote cessation in smokers not ready to quit?

Authors:  Taghrid Asfar; Jon O Ebbert; Robert C Klesges; George E Relyea
Journal:  Addict Behav       Date:  2011-02-12       Impact factor: 3.913

3.  Evaluation of the cognitive behavioral smoking reduction program "Smoke_less": a randomized controlled trial.

Authors:  Tobias Rüther; Alexa Kiss; Kerstin Eberhardt; Andrea Linhardt; Christoph Kröger; Oliver Pogarell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-06-14       Impact factor: 5.270

4.  Bridging the gap between research and practice: an assessment of external validity of community-based physical activity programs in Bogotá, Colombia, and Recife, Brazil.

Authors:  Diana C Paez; Rodrigo S Reis; Diana C Parra; Christine M Hoehner; Olga L Sarmiento; Mauro Barros; Ross C Brownson
Journal:  Transl Behav Med       Date:  2015-03       Impact factor: 3.046

Review 5.  The RE-AIM framework: a systematic review of use over time.

Authors:  Bridget Gaglio; Jo Ann Shoup; Russell E Glasgow
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

6.  An EHR-automated and theory-based population health management intervention for smoking cessation in diverse low-income patients of safety-net health centers: a pilot randomized controlled trial.

Authors:  Brian Hitsman; Phoenix A Matthews; George D Papandonatos; Kenzie A Cameron; Sarah S Rittner; Nivedita Mohanty; Timothy Long; Ronald T Ackermann; Edgardo Ramirez; Jeremy Carr; Emmanuel Cordova; Cherylee Bridges; Crystal Flowers-Carson; Aida Luz Giachello; Andrew Hamilton; Christina C Ciecierski; Melissa A Simon
Journal:  Transl Behav Med       Date:  2022-10-07       Impact factor: 3.626

7.  Lessons learned from recruiting socioeconomically disadvantaged smokers into a pilot randomized controlled trial to explore the role of Exercise Assisted Reduction then Stop (EARS) smoking.

Authors:  Tom P Thompson; Colin J Greaves; Richard Ayres; Paul Aveyard; Fiona C Warren; Richard Byng; Rod S Taylor; John L Campbell; Michael Ussher; Susan Michie; Robert West; Adrian H Taylor
Journal:  Trials       Date:  2015-02-12       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.